Nocturnal growth hormone release in children with short stature and atopic dermatitis

T J David1, A P Ferguson, R W Newton

  • 1Department of Child Health, University of Manchester, England.

Insights

Children with atopic dermatitis and short stature may have impaired growth hormone release during sleep. This contrasts with normal sleep-related growth hormone release in healthy children, suggesting a specific sleep-related deficiency in affected children.

Area of Science:

  • Pediatric Endocrinology
  • Dermatology
  • Sleep Medicine

Background:

  • Atopic dermatitis is a chronic inflammatory skin condition.
  • Short stature in children can have various underlying causes.
  • Growth hormone (GH) is crucial for childhood growth and development.

Purpose of the Study:

  • To investigate the hypothesis that children with atopic dermatitis and short stature exhibit impaired nocturnal growth hormone release.
  • To compare GH secretion during sleep with GH response to arginine stimulation in children with atopic dermatitis and short stature.

Main Methods:

  • Compared peak serum GH levels during sleep with peak GH response to arginine stimulation.
  • Studied 6 children (7-12 years) with atopic dermatitis and short stature (<-3 SD).
  • Included 5 control children (9-12 years) with unexplained short stature.

Main Results:

  • All 5 control children demonstrated normal GH release during sleep.
  • 3 out of 6 children with atopic dermatitis did not achieve normal GH levels during sleep.
  • All children with atopic dermatitis showed normal GH release following arginine stimulation.

Conclusions:

  • Prepubertal children with atopic dermatitis and short stature may experience impaired growth hormone release during stage 4 sleep.
  • The findings suggest a potential sleep-related mechanism affecting GH secretion in this specific pediatric population.
  • Arginine stimulation indicates the pituitary's capacity to release GH, pointing to a sleep-specific issue.